Skip to content

Study on the Efficacy and Brain Mechanism of Dual-Target Transcranial Alternating Current Stimulation in Improving Cognitive Dysfunction after Stroke

Study on the Efficacy and Brain Mechanism of Dual-Target Transcranial Alternating Current Stimulation in Improving Cognitive Dysfunction after Stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120303
Enrollment
Unknown
Registered
2026-03-12
Start date
2026-03-31
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

The sham stimulation group:tACS sham stimulation
Single-target group:Single-target tACS
Dual-target group:Dual-target tACS

Sponsors

Shanghai Seventh People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age: 45 - 75 years old, gender not restricted, normal vision or corrected vision; 2. Meets the diagnostic criteria of the "Combined Diagnosis Standards for Cerebral Infarction and Cerebral Hemorrhage (Trial)" in 2006, and has been confirmed by head CT or MRI examination; 3. Has cognitive dysfunction as assessed by MoCA-BJ (total score = 25 points); 4. Cognitive function was normal before the onset; 5. First episode; 6. Disease course = 3 months, stable condition, stable vital signs; 7. Can maintain a sitting position for 30 minutes or more independently; 8. Clear consciousness, no aphasia or hemispatial neglect, able to understand the content of the scale and cooperate with examinations and treatments; 9. Voluntarily sign the informed consent form and understand the research content.

Exclusion criteria

Exclusion criteria: 1. Patients with critical illness or whose acute condition has not yet stabilized; 2. Those with complete frontal lobe damage confirmed by CT or MRI; 3. Patients with bilateral brain damage; 4. Those meeting the diagnostic criteria for post-stroke depression as stipulated in the "Chinese Expert Consensus on Clinical Practice of Post-Stroke Depression" ; 5. Patients diagnosed with any other neurological disorder; 6. Patients with hearing loss, aphasia or severe cognitive impairment, making normal communication difficult; 7. Patients with severe cardiovascular or other serious health problems; 8. Patients unable to cooperate with the rehabilitation plan of this study; 9. Patients concurrently participating in other clinical trials; 10. Patients unable to understand or unable to sign the informed consent form; 11. Patients with any contraindications for tACS or EEG, such as having a pacemaker, cochlear implant, or metal implants in the brain; 12. Other situations deemed inappropriate for participation in this study by the researchers.

Design outcomes

Primary

MeasureTime frame
MoCA-BJ Score;

Secondary

MeasureTime frame
Digital breadth ;Modified Bacterial Index;EEG-related data;

Countries

China

Contacts

Public ContactXiaoming Yu

Shanghai Seventh People's Hospital (Seventh People's Hospital Affiliated to Shanghai University of Traditional Chinese Medicine)

yuxiaomg@126.com+86 181 4976 5681

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026